Evidence Based Investments
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I think the recent news of the honeywell sale, there are ppl (outside of this board) accumulating. We saw a nice pop from that, but the wording in the joint presentation with honeywell, which seems to been made by honeywell, points towards the idea that they are looking to commercialize deform, as they are a joint developer and most likely have the ability to do so if it makes financial sense for them to do so.
They say in the presentation, they are looking to be a leader in AM technology in the world.
I have a feeling they understand the power of deform and are looking to leverage their jtda with sglb, which would be amazing for sglb as they don't have the personnel nor global network to do it themselves.
I was leaning towards ge being a lucrative deal but now I feel honeywell may be even more substantial as a partner for sglb.
More volume doesn't mean anything.
On a broader exchange, we would have more visibility, but it would most likely hurt us bc every investor would see we are over 10x our assets and short us until are valuation is a fraction of what it is now.
We need cash or sales before moving anywhere.
Most are valued by their current assets and sales.
Future prospects may be taken into consideration, but never completely dependent on a company's valuation as ours is now.
At this point we are still over valued,
moving onto a broader exchange would
most likely only hurt us at this point
having no cash, no sales.
It seems the gameplan is to post significant
revenues from one of the big boys they have
been working with the past few years,
raise capital, and then uplist.
Our valuation has been sitting pretty generously
and seems to be holding there relatively well.
Until we have cash or sales, we are at risk of
seeing our valuation drop extremely low.
Most likely the reason not many people are
ready to get in yet.
We are all gambling on the idea that GE and/or
Honeywell are going to need SGLB software
in a big way.
Until that happens, SGLB is going to remain
in the shadows, with an outrageously high
valuation for a company with nothing on the
balance sheet. Risky for investors, but those
who have done the DD know where SGLB
will be soon.
Dear .07,
Please hold!!!
sincerely, sglb investor
On a serious note, excited to see the terms of
the Honeywell sale.
Hoping for Additive Industries to mention
SGLB in their upcoming presentation.
Still waiting on GE on the backburner, not
expecting to hear from them until q3, q4.
We shall see. Should be a good year for SGLB.
Added today. Seemed to be decent buying goin on, so hoping the trend reverses.
Too many near term possibilities.
Next ER should be interesting to see the terms of the honeywell sale and hopefully deform release sooner than that.
Don't know if this has been posted before,
sort of old news but still interesting to
see that SGLB was mentioned as a
leader amongst 3D printing companies
in the United states in this research paper.
http://www.researchandmarkets.com/research/9cm2gz/global_and
im sure he had a handful lol
not sure if GE is getting brand new
shiny 290's like sglb got
the one in the video is a 270
either way, im so ready for full production
and GE to contract sglb for about
15 PR3D systems and a royalty program.
Oh and Honeywell too,
Notice that EOS machine had a number 8 on top of it...
I wonder how many are in the series....
SGLB baby!!!!
Called it, broke 4 week lows,
Waiting and watching for best price
Once GE moves to full production, expected before the end of this
year, SGLB will most certainly receive at least some sort of percentage
portion based on the predetermined agreement within the JTDA.
Since SGLB is the patent holder and main developer of the hardware/software
platform, it should be a decent amount.
If GE plans on using the hardware/software developed between the two companies,
they will definitely have to pay SGLB a percentage to use this co-developed product.
http://www.geaviation.com/press/other/other_20130524.html
You must have forgot about the JTDA GE and SGLB have had going
on for two years now, where Mark Cola has said on multiple occasions
in recent ER reports that the JTDA is still in effect and they are in "lock step"
with GE to advance and implement in-process inspection technologies for additive manufactured jet engine components.
Production before the end of the year sounds good to me.
Just make sure SGLB gets some good money rolling in to
help us pay the bills!
Accumulation/Distribution showing heavy selling
the past 10 days. On the month we are still in
the positive but somewhere inbetween 10 days
and a month we are pretty deep in the red.
Someone either sold big or shorted big, which
could cause the downtrend to continue until
the majority selling stops.
I agree with him on that one, 4 week low support
running thin over the past couple weeks.
May break and cause a bit of a drop.
No worries though, just good buying prices.
Looks like the 4 week low support is wearing thin,
looks (imo) like it will soon break as shorting,selling
continues. Still have a long stretch until the next
ER in mid-august, unless they decide to drop
a juicy PR before then, or release news of revenues.
Holding funds for now, looking to add in the
.055-.075 range as that is around where any
decent support stands for now.
Found this evem more compelling within the special requirements, section C1
Required by the FAA for the leap engine.
An engineering plan, which establishes and maintains that the combinations of loads, material properties, environmental influences, and operating conditions, including the effects of parts influencing these parameters, are well known or predictable through validated analysis, test, or service experience.
Its lookimg good for sglb...I'm loadin up!
After a substantial contract (multimillion dollars) utlization of the s3 on the news, a r/s with a subsequent uplististing, we will be in a much better position.
However, this 20x asset dreamland will be out the window. But, with the (possible) contract news and raising of 25 million in cash thru the s3, sglb may be able to hold a 4-5x cash valuation at around 100million if I were to guess. And that's still mainly bc of the companies they're dealing with and the high cagr of the market.
Dude, no way sglb holds a 75x multiple once they get to the big leagues (ie. Uplist), for a company with no personnel, marketing, assets, entering a small market (estimated to be around 10 billion in the near future).
Its holding about 20x cash now only bc of the possibilities of a large contract to quickly counteract that valuation, allowing any additional contracts to move the pps north.
The idea that sglb will somehow hold 75x multiple on their earnings is insane.
Unfortunately, the company lacks cash and/or sales to account for their current valuation. News of sales may prop up the pps enough for sglb to utilize the s3 which would quickly give them a great cash position going forward.
But a company with a couple million in cash and little revenue coming in and valued at $50 million is still a risk to shareholders.
Although our relationships with potential big buyers exists, it is still going to take that lump sum to prove our valuation. Obviously the market believes this is a possibility as sglb has held in this range for awhile now.
Sglb is still a huge sale and a dilution away from greatness. After that short pain, which may still hold above the current valuation, sglb will be a major player in the AM space.
We've been having this conversation for years now...will they get bought out? Will they merge? They need sales to prove their valuation.
Starting to sound like a broken record.
This same old song and dance is getting old but at least the company has made progress with various companies that will hopefully result in multiple revenue streams.
I think their valuation is high for their current situation, but any deal with the companies they've been cooperating with would verify their technology, proving it could be used for much of the quickly evolving AM market which is projected to hit <10 billion in the upcoming years. If the technology is already playing a vital role in the few leaders of the industry, its safe to say sglb can easily capture a small percentage of the market.
SGLB is still risky, but a calculated risk.
Its still a company with limited funds, limited personnel, dealing with a technology that has yet to record any sales.
For the little cash and assets sglb holds it is a very high valuation.
We have limited PR and No marketing team.
This is a project in the works and once news hits of a contract with GE and/or Honeywell for any substantial amount of money or royalty payments, this valuation will be long gone.
I like the fact sglb isn't on the front pages yet. Might make gains more prominent in the long run.
If there was it was not intentional
Lol.
Just coming from my phone.
Looks like were still stuck in
Limbo until the release of deform
Or news of pr3d contracts...
Otherwise its speculation and
MM/short games until next
ER mid august. Waiting to see
The terms of the unit sold to
Honeywell, which is hopefully
Lucrative for sglb.
Ill be buying dips, kind of OK
With the price action as it is
Giving me some time to
Accumulate. Sometimes
Feel crazy going in a this
Little OTC company. But I
Believe this technology is
Very valuable to the soon
To be monumental AM industry.
If this downtrend continues and breaks thru
the current support again it could take a big
hit.
No support between .0786 and .0539.
Patiently waiting to see how this goes
over the next few days or week.
Funds clearing tmrw so hopefully the
direction will be more obvious bc
right now it looks like it could go either
way.
Looks like .083 is holding so far
Not sure if the shorting will continue
Into next week.
Could be a bit of a drop down if it does.
My cash clears on monday so hopefully we will see then
which was supposed to happen q1 of 2015
which means merck isn't that interested in it
which means oncosec will most likely be footing
the bill.
which means years of trials and millions of dollars.
"Imminent Trial with Merck?"
Up to this point we have absolutely nothing going on
with keytruda or Merck.
Not to mention that has to start at ground zero and
will take very long to finish all the trials.
And 42 million isn't that much when you spend approximately
23 million per year and have no sight of revenues in that remaining
time period.
ONCS has only been able to spend money and forced to go on
trials alone for the most part or at least where they are the only
entity spending money and paying someone else to do the work.
Only hope is waiting for trial data in December.
Burning thru cash until then.
Suspecting the downtrend may continue into the low to mid 4's once this
NASDAQ dust settles. Company seems to be in a hard funding phase
with the startup of all these trials and R&D costs. Short term outlook
seems a little dismal but the long term benefits should be worth a little
pain.
Good buying opportunity coming for longs.
Interesting by August he is giving a very similar presentation
as he just did with SGLB, just alone. Maybe by then
Honeywell will have a joint product with SGLB that they
can begin distributing worldwide not only within their
own company but abroad if they are willing to share
the technology for a pretty penny.
Sigma Labs and Honeywell RAPID 2015 Conference
Partnership continues.
http://sigmalabsinc.com/uploads/Events/RAPID%202015%20Non%20Destructive%20Evaluation%20Techniques%20for%20Additive%20Manufacturing%20-%20Joint%20Technology%20Development%20Between%20Honeywell%20Corporation%20and%20Sigma%20Lab.pdf
Main points I saw besides the impressive advancement of the technology compared to current alternatives, as well as the appearance that Honeywell is completely comfortable with slapping SGLB all over their name and integrity in this document and the conference itself. But they also seem to be ready to scale this product and with their global distribution network and prestige in the area of AM, DEFORM seems to be a product they really believe in. Maybe they will work with us in ways we never even imagined.
Honeywell incorporating AM on Global Scale
• Working to be world leader in technology development in
the area of in-process NDE for AM
• Objective Evidence of Compliance to Design Intent is the ultimate goal
They're getting paid by ONCS for the study whether it
works or not. They don't care either way.
Would they like to see positive results? Sure,
it makes everyone look smart.
Do they care/are they to blame if it doesn't?
No.
But the timing of the r/s is hurting their valuation
which affects all entities and shareholders including
Punit himself.
With the recent spending on R&D and the entering
into long and expensive trials, it would seem they
are really in need of cash, and are willing to take
a huge hit on their valuation just to get access to
the type of monies they need. Looks like a lot
of dilution in the making, which ONCS has already
done their fair share of.
This is not a success.
If the rs was done at a reasonable time with good news this move would make sense. But as of now, losing 20 percent
And possibly more on our investment is not a great way to show shareholders the company cares about value.
Have to vent somewhere.
This was the worst possible timing for a R/S
No milestones, no revenue, burning cash,
no partnerships, nothing.
We are going to lose a good chunk of our
valuation for the foreseeable future as we
have already seen two days into the announcement
of an r/s.
Terrible management decision.
They better have something waiting for once
we are on the NASDAQ otherwise our valuation
will be the lowest since inception of the company.
Terrible.
Thanks guys!
Sorry don't usually ask ppl to do my DD for me but I'm out of the office
and am crunched on time here...is the Conference call only on the phone
or is there a webcast as well.
Thank You fellow sigmaniacs!
It is clearly a mistake for ONCS to make this move at
the current time. They are far from revenues and
have only raised cash thru dilution. This is not
attractive to the "big bankers" who only deal
on the NASDAQ.
I have a feeling our valuation will take a thick
cut over the next few months, as all we have
been doing is burning thru cash and eventually
need more.
Only thing that would save us near term is trial
results or partnership with a company with money
willing to fund a trial.
These things don't seem imminent so it looks like
we will be buying at new valuation lows here pretty
soon.
I believe in the long term success of the technology
but it seems we have a longer way to go than I would
have hoped.
Saving my cash to buy at probably a $30 million valuation
or less. Unfortunate.
From my understanding is they are developing their own
printer. The main concern they are targeting is creating
a printer that can handle mass production while maintaining
high quality. Also looking to increase print speed. A tall order
but a necessity to really bring AM to commercial grade production.
As AM moves from small lot prototyping to mass production
of parts, this is the main issue as to why AM has not made
it to the market, because you can only print so many parts
at a time. They are looking to fix this issue.
3D print sector got slammed today.
Yes this is still a upcoming technology, the revenues are not tangible yet for those producing printers and/or producing parts themselves.
Once the realization this can save major money, means it is worth major money.
Time is the only thing in our way.